Movatterモバイル変換


[0]ホーム

URL:


FR2722199B3 - VALPROIC ACID DERIVATIVES AND THEIR APPLICATIONS AS MEDICAMENTS - Google Patents

VALPROIC ACID DERIVATIVES AND THEIR APPLICATIONS AS MEDICAMENTS

Info

Publication number
FR2722199B3
FR2722199B3FR9408542AFR9408542AFR2722199B3FR 2722199 B3FR2722199 B3FR 2722199B3FR 9408542 AFR9408542 AFR 9408542AFR 9408542 AFR9408542 AFR 9408542AFR 2722199 B3FR2722199 B3FR 2722199B3
Authority
FR
France
Prior art keywords
medicaments
applications
acid derivatives
valproic acid
valproic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9408542A
Other languages
French (fr)
Other versions
FR2722199A1 (en
Inventor
Vincent Guy Armand
Jacques Louvel
Denis Ghislain Postel
Rene Daniel Ghislain Pumain
Gino Lino Ronco
Pierre Joseph Villa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Picardie Jules Verne
Original Assignee
Universite de Picardie Jules Verne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Picardie Jules VernefiledCriticalUniversite de Picardie Jules Verne
Priority to FR9408542ApriorityCriticalpatent/FR2722199B3/en
Publication of FR2722199A1publicationCriticalpatent/FR2722199A1/en
Application grantedgrantedCritical
Publication of FR2722199B3publicationCriticalpatent/FR2722199B3/en
Anticipated expirationlegal-statusCritical
Expired - Fee Relatedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

FR9408542A1994-07-111994-07-11 VALPROIC ACID DERIVATIVES AND THEIR APPLICATIONS AS MEDICAMENTSExpired - Fee RelatedFR2722199B3 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
FR9408542AFR2722199B3 (en)1994-07-111994-07-11 VALPROIC ACID DERIVATIVES AND THEIR APPLICATIONS AS MEDICAMENTS

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
FR9408542AFR2722199B3 (en)1994-07-111994-07-11 VALPROIC ACID DERIVATIVES AND THEIR APPLICATIONS AS MEDICAMENTS

Publications (2)

Publication NumberPublication Date
FR2722199A1 FR2722199A1 (en)1996-01-12
FR2722199B3true FR2722199B3 (en)1996-09-06

Family

ID=9465227

Family Applications (1)

Application NumberTitlePriority DateFiling Date
FR9408542AExpired - Fee RelatedFR2722199B3 (en)1994-07-111994-07-11 VALPROIC ACID DERIVATIVES AND THEIR APPLICATIONS AS MEDICAMENTS

Country Status (1)

CountryLink
FR (1)FR2722199B3 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE19534519A1 (en)*1995-09-051997-07-10Desitin Arzneimittel Gmbh Sugar or sugar alcohols for use as an anti-epileptic
EP2350109A4 (en)2008-10-202015-03-11Chemyunion Química LtdaXylitol esters and ethers applied as alternative emulsifiers, solvents, co-emulsifiers and preservative systems for pharmaceutical and cosmetic products
WO2014037832A2 (en)*2012-09-062014-03-13Mahesh KandulaCompositions and methods for the treatment of epilepsy and neurological diseases
US9738631B2 (en)2012-05-072017-08-22Cellix Bio Private LimitedCompositions and methods for the treatment of neurological disorders
US9399634B2 (en)2012-05-072016-07-26Cellix Bio Private LimitedCompositions and methods for the treatment of depression
AU2013257742A1 (en)2012-05-072014-11-27Cellixbio Private LimitedCompositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
WO2013167992A1 (en)2012-05-082013-11-14Mahesh KandulaCompositions and methods for the treatment of inflammatory disorders
US9522884B2 (en)2012-05-082016-12-20Cellix Bio Private LimitedCompositions and methods for the treatment of metabolic disorders
US9266823B2 (en)2012-05-082016-02-23Cellix Bio Private LimitedCompositions and methods for the treatment of parkinson's disease
WO2013167993A1 (en)2012-05-082013-11-14Mahesh KandulaCompositions and methods for the treatment of neurological degenerative disorders
WO2013168025A1 (en)2012-05-082013-11-14Mahesh KandulaCompositions and methods for treatment of blood clotting disorders
US9315478B2 (en)2012-05-102016-04-19Cellix Bio Private LimitedCompositions and methods for the treatment of metabolic syndrome
US9403857B2 (en)2012-05-102016-08-02Cellix Bio Private LimitedCompositions and methods for the treatment of metabolic syndrome
WO2013167999A2 (en)2012-05-102013-11-14Mahesh KandulaCompositions and methods for the treatment of neurologic diseases
US9339484B2 (en)2012-05-102016-05-17Cellix Bio Private LimitedCompositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9273061B2 (en)2012-05-102016-03-01Cellix Bio Private LimitedCompositions and methods for the treatment of chronic pain
US9394288B2 (en)2012-05-102016-07-19Cellix Bio Private LimitedCompositions and methods for the treatment of asthma and allergy
WO2013168033A1 (en)2012-05-102013-11-14Mahesh KandulaCompositions and methods for treatment of neurologic diseases
WO2013168000A1 (en)2012-05-102013-11-14Mahesh KandulaCompositions and methods for the treatment of severe pain
WO2013168001A1 (en)2012-05-102013-11-14Mahesh KandulaCompositions and methods for the treatment of moderate to severe pain
WO2013168004A2 (en)2012-05-102013-11-14Mahesh KandulaCompositions and methods for the treatment of fibromyalgia pain
WO2013168012A1 (en)2012-05-102013-11-14Mahesh KandulaCompositions and methods for the treatment of respiratory disorders
US9233161B2 (en)2012-05-102016-01-12Cellix Bio Private LimitedCompositions and methods for the treatment of neurological conditions
US9499527B2 (en)2012-05-102016-11-22Cellix Bio Private LimitedCompositions and methods for the treatment of familial amyloid polyneuropathy
NZ701832A (en)2012-05-232016-08-26Cellix Bio Private LtdCompositions and methods for treatment of inflammatory bowel disease
CA2873104A1 (en)2012-05-232013-11-28Cellixbio Private LimitedCompositions and methods for the treatment of mucositis
WO2013175344A2 (en)2012-05-232013-11-28Mahesh KandulaCompositions and methods for the treatment of periodontitis and rheumatoid arthritis
US9227974B2 (en)2012-05-232016-01-05Cellex Bio Private LimitedCompositions and methods for the treatment of respiratory disorders
EP2852569B1 (en)2012-05-232020-10-14Cellixbio Private LimitedCompositions and methods for the treatment of multiple sclerosis
WO2013175376A2 (en)2012-05-232013-11-28Mahesh KandulaCompositions and methods for the treatment of local pain
US9108942B1 (en)2014-11-052015-08-18Mahesh KandulaCompositions and methods for the treatment of moderate to severe pain
WO2014020480A2 (en)2012-08-032014-02-06Mahesh KandulaCompositions and methods for the treatment migraine and neurologic diseases
WO2014037833A2 (en)2012-09-062014-03-13Mahesh KandulaCompositions and methods for the treatment inflammation and lipid disorders
SG11201407325YA (en)2012-09-082014-12-30Cellix Bio Private LtdCompositions and methods for treatment of inflammation and lipid disorders
US9333187B1 (en)2013-05-152016-05-10Cellix Bio Private LimitedCompositions and methods for the treatment of inflammatory bowel disease
SG11201509782TA (en)2013-06-042015-12-30Cellix Bio Private LtdCompositions and methods for the treatment of diabetes and pre-diabetes
US10227301B2 (en)2015-01-062019-03-12Cellix Bio Private LimitedCompositions and methods for the treatment of inflammation and pain
US9096537B1 (en)2014-12-312015-08-04Mahesh KandulaCompositions and methods for the treatment of mucositis
NZ736131A (en)2014-09-262019-04-26Cellix Bio Private LtdCompositions and methods for the treatment of epilepsy and neurological disorders
CN107207403A (en)2014-09-292017-09-26塞尔利克斯生物私人有限公司Composition and method for treating multiple sclerosis
CN107108535B (en)2014-10-272020-04-28塞尔利克斯生物私人有限公司Three-component salts of monomethyl fumarate with piperazine or ethylenediamine for the treatment of multiple sclerosis
US9290486B1 (en)2014-11-052016-03-22Cellix Bio Private LimitedCompositions and methods for the treatment of epilepsy
US9175008B1 (en)2014-11-052015-11-03Cellix Bio Private LimitedProdrugs of anti-platelet agents
US10208014B2 (en)2014-11-052019-02-19Cellix Bio Private LimitedCompositions and methods for the treatment of neurological disorders
US9150557B1 (en)2014-11-052015-10-06Cellix Bio Private LimitedCompositions and methods for the treatment of hyperglycemia
US9284287B1 (en)2014-11-052016-03-15Cellix Bio Private LimitedCompositions and methods for the suppression of carbonic anhydrase activity
US9321716B1 (en)2014-11-052016-04-26Cellix Bio Private LimitedCompositions and methods for the treatment of metabolic syndrome
US9173877B1 (en)2014-11-052015-11-03Cellix Bio Private LimitedCompositions and methods for the treatment of local pain
US9932294B2 (en)2014-12-012018-04-03Cellix Bio Private LimitedCompositions and methods for the treatment of multiple sclerosis
US9206111B1 (en)2014-12-172015-12-08Cellix Bio Private LimitedCompositions and methods for the treatment of neurological diseases

Also Published As

Publication numberPublication date
FR2722199A1 (en)1996-01-12

Similar Documents

PublicationPublication DateTitle
FR2722199B3 (en) VALPROIC ACID DERIVATIVES AND THEIR APPLICATIONS AS MEDICAMENTS
EP0782399A4 (en) HYDROXYCITRIC ACID CONCENTRATE AND MANUFACTURING METHOD THEREOF
EP1005562A4 (en) PRODUCTION AND PURIFICATION OF SUCCINIC ACID
BR9510256A (en) Derivatives of 3-aryl-tetronic acid
NO950785D0 (en) fatty acid derivatives
FR2737122B1 (en) STABLE COMPOSITION CONTAINING ASCORBIC ACID
DZ2800A1 (en) New derivative of 3-aryl-2-hydroxypropionic acid.
FR2596393B1 (en) HYDROXY-3 DIHYDROXYOXOPHOSPHORIO-4 BUTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
EP0961614A4 (en) OXYALKYLESTERS CONTAINING TRICARBOXYLIC ACID AND USES THEREOF
FI953139L (en) Pharmaceutical compositions comprising atovaquone
FI950909L (en) Fatty acid derivatives
FR2696740B1 (en) Produced derivatives of dimethylbiguanide and applications as medicaments.
EE9500059A (en) Use of substituted 4-phenyl-6-aminonicotinic acid derivatives as medicaments
DE69514976D1 (en) Polyamic acid solution
FR2682679B1 (en) NOVEL ALKYLPOLYOSIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND APPLICATIONS AS SURFACE AGENTS.
FR2709679B1 (en) Concentrated aqueous compositions of alkylpolyglycosides and their uses.
DE69528440D1 (en) Microorganism producing 5-aminolevulinic acid
MA23475A1 (en) 5-VINYL AND 5-ETHINYL -QUINOLONE AND NAPHTYRIDONE -CARBOXYLIC ACID.
FR2723945B1 (en) PROCESS FOR THE MANUFACTURE OF 2,5-FURANE DICARBOXYLIC ACID
FR2691708B1 (en) BIS-DITHIOPHOSPHORIC ACID DERIVATIVES AS ADDITIVES IN LUBRICANTS.
FR2643371B1 (en) NOVEL 2-AMINO PENTANEDIOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2560881B1 (en) SIALIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATIONS IN PARTICULAR AS A CANCER CELL METASTASE INHIBITOR
MA23133A1 (en) DERIVATIVES OF ACYLOXYHEXANOIC ACID.
MC1960A1 (en) HYDROCINNAMIC ACID DERIVATIVES
FR2757165B1 (en) ESTER OF MALEIMIDOBENZOIC ACID

Legal Events

DateCodeTitleDescription
STNotification of lapse

[8]ページ先頭

©2009-2025 Movatter.jp